Nav: Home

Advanced stage NSCLC patients receiving treatment have better OS than untreated patients

January 18, 2017

DENVER - Non-small cell lung cancer (NSCLC) patients with advanced disease receiving standard of care treatment have a higher overall survival (OS) than similar patients not receiving treatment.

Lung cancer is the leading cause of cancer deaths worldwide, causing more deaths than breast, colon, and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for roughly 85% of lung cancers. Despite new and improved treatment regimens and improved clinical trial enrollment, the 5-year survival for advanced NSCLC (Stage III-IV) is approximately 1% - 14%. Standard treatment for patients with advanced disease often includes a combination of radiation therapy, chemotherapy, and/or surgery in highly selective circumstances. Despite these standard treatment guidelines, a substantial proportion of NSCLC patients remain untreated.

A group of California, USA researchers, led by Dr. Elizabeth A. David, conducted a study to evaluate treatment trends and their association with overall survival on patients with NSCLC. The group queried the National Cancer Database (NCDB) for cases of biopsy-proven NSCLC from 1998-2012. Patients with NSCLC that had histological data available were included in the study. Propensity matching was used to identify untreated patients who were similar to patients that underwent standard treatment regimens as well as to compare survival among subsets of treated versus untreated patients. Linear regression analysis was used to determine the trend in treatment over the study period, using the proportion of patients who received treatment at a certain year as a continuous variable as the outcome. Overall survival was estimated using Kaplan-Meier method within treatment groups. Multivariate Cox proportional hazards model was used to study the association of each of the variables on OS. Multivariable logistic regression model was used to study the association of each of the variables with being untreated.

The results of the study published in the Journal of Thoracic Oncology, the official journal of the International Association for the Study of Lung Cancer (IASLC), showed that 190,539 (21%) of patients identified from the NCDB received no treatment. For stage IIIA and IV, the proportion of untreated patients increased over the study period (1998-2012) by 0.21% (p = 0.003) and 0.40% (p < 0.0001), respectively. Regardless of stage, untreated patients had significantly shorter OS (p < 0.0001). Propensity-matched analysis of 6,144 stage IIIA patient pairs demonstrated a higher OS for patients treated with chemoradiation (16.5 months) versus no treatment (6.1 months, p < 0.0001). Similarly, stage IV patient pairs (19,046) had a higher OS when treated with chemotherapy (9.3 months) versus no treatment (2.0 months, p < 0.0001).

The authors comment that, "The OS of advanced stage patients receiving treatment is significantly better than patients not receiving treatment. Unfortunately, the proportion of untreated advanced stage patients is increasing. There are many factors that influence the decision not to undergo treatment for NSCLC, including patient and disease characteristics, as well as physician factors. Physician referral patterns and preferences may influence the delivery and guideline-based therapy received by patients. Patient factors such as rural location, socioeconomic disparities, age of patients, and insurance status may also influence physician referral patterns and treatment decisions. Physicians should ensure that patients from disparate populations are evaluated and counseled thoroughly by multidisciplinary teams before choosing to forego treatment for NSCLC."
-end-
Co-authors Megan Daly, David Cooke, Lisa Brown, and Karen Kelly are members of IASLC.

About the IASLC

The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated to the study of lung cancer. Founded in 1974, the association's membership includes more than 5,000 lung cancer specialists in over 100 countries. Visit http://www.iaslc.org for more information.

Written by: Jacinta Wiens, PhD, 720-598-1941; jacinta.wiens@iaslc.org

Media Contact: Becky Bunn, 720-254-9509; Becky.Bunn@iaslc.org

International Association for the Study of Lung Cancer

Related Lung Cancer Articles:

AI helps to fight against lung cancer
Lung cancer has been the leading cause of cancer-related deaths in 2015 in United States.
Free lung-cancer screening in the Augusta area finds more than double the cancer rate of previous screenings
The first year of free lung cancer screening in the Augusta, Ga., area found more than double the rate seen in a previous large, national study as well as a Massachusetts-based screening for this No.
Antioxidants and lung cancer risk
An epidemiological study published in Frontiers in Oncology suggests that a diet high in carotenoids and vitamin C may protect against lung cancer.
Lung cancer may go undetected in kidney cancer patients
Could lung cancer be hiding in kidney cancer patients? Researchers with the Harold C.
Hitgen and Cancer Research UK's Manchester Institute enter license agreement in lung cancer
Cancer Research UK, Cancer Research Technology (CRT), the charity's commercial arm, and HitGen Ltd, a privately held biotech company focused on early drug discovery, announced today that they have entered into a licence agreement to develop a novel class of drugs against lung cancer.
Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Huntsman Cancer Institute research holds promise for personalized lung cancer treatments
New research from scientists at Huntsman Cancer Institute (HCI) at the University of Utah uncovered distinct types of tumors within small cell lung cancer that look and act differently from one another.
High levels of estrogen in lung tissue related to lung cancer in postmenopausal women
Researchers from Kumamoto University, Japan have found that postmenopausal women with multicentric adenocarcinoma of the lung have a higher concentration of estrogen in non-cancerous areas of the peripheral lung than similar women diagnosed with single tumor lung cancer.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Pericardial window operation less efficient in cases of lung cancer than any other cancer
Pericardial window operation, a procedure, where abnormal quantity of malignant fluid, surrounding the heart, is drained into the neighbouring chest cavity, is commonly applied to patients diagnosed with cancer.

Related Lung Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Jumpstarting Creativity
Our greatest breakthroughs and triumphs have one thing in common: creativity. But how do you ignite it? And how do you rekindle it? This hour, TED speakers explore ideas on jumpstarting creativity. Guests include economist Tim Harford, producer Helen Marriage, artificial intelligence researcher Steve Engels, and behavioral scientist Marily Oppezzo.
Now Playing: Science for the People

#524 The Human Network
What does a network of humans look like and how does it work? How does information spread? How do decisions and opinions spread? What gets distorted as it moves through the network and why? This week we dig into the ins and outs of human networks with Matthew Jackson, Professor of Economics at Stanford University and author of the book "The Human Network: How Your Social Position Determines Your Power, Beliefs, and Behaviours".